Using Indirect Comparisons of Prospective, Randomized Trials to Make Therapeutic Decisions in Melanoma: Cross-Trial Comparisons as Surrogates for Proper Head-To-Head Studies? Clinical trials are ...
Background Chromosome 19 is the most gene-dense chromosome in the human genome, with a high frequency of segmental duplications that predispose it to genomic rearrangements. While deletions of ...
Selective JAK1 Inhibitors for Treatment of Atopic Dermatitis Review the role of the JAK/STAT pathway in atopic dermatitis, and the pharmacology of the JAK1 inhibitors upadacitinib and abrocitinib, ...
Medical learners in the 21st century spend less time with patients during training than their counterparts did in the 20th century, which decreases the knowledge and practice of bedside clinical ...
Celltrion announced on April 2 that a paper detailing the results of a post-hoc analysis from the global Phase 3 clinical trial of 'Zympendra' (the ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
Clinicians routinely provide harm-reduction measures and anticipatory guidance for a range of complex health issues (e.g., substance use and vaccination), capitalizing on available evidence, their ...
Children with the rare but serious allergic disease FPIES have an atypical gut microbiota compared to healthy children. This ...
Renowned clinical researcher and CEO of the Baim Institute Dr. Gibson joins DrKumo to drive innovation in pharma ...
WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA ® (finerenone) significantly reduced urine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results